Inotrem

Inotrem

Inotrem

INOTREM SA is a biopharmaceutical company discovering and developing firstinclass immunotherapies for the treatment of inflammatory diseases.
Type
B2b
Founded
2013
Raised
$44.3M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
€19,000,000
Venture capital (Series B) - 2020
Bpifrance Kreos Capital Fountain Healthcare Partners
$23,158,800
Venture capital (Series A) - 2014
Team Size
1–10
Employees
Location
Headquarters
€19,000,000 Venture capital (Series B)
FinSMEs

Inotrem Raises €19M in Funding